Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Sell
1,373
-7,000
-84% -$3M 0.04% 474
2025
Q4
$3.58M Buy
8,373
+1,084
+15% +$472K 0.28% 119
2025
Q3
$3.26M Buy
+7,289
New +$3.3M 0.25% 116
2022
Q1
Sell
-1,795
Closed -$950K 222
2021
Q4
$950K Buy
+1,795
New +$862K 0.16% 112
2021
Q3
Sell
-2,083
Closed -$988K 324
2021
Q2
$988K Buy
2,083
+1,243
+148% +$597K 0.12% 124
2021
Q1
$386K Buy
+840
New +$412K 0.06% 170

Other funds holding CHE

Atom Investors's CHE Position: Q1 2026 in Review

Atom Investors reduced its Chemed (CHE) stake by 84% in Q1 2026, selling an estimated $3M and leaving 1,373 shares worth $519K. The position accounts for 0.04% of the portfolio, ranked #474.

Atom Investors first reported a position in CHE in Q1 2021 and has held it in 6 quarters since. The position peaked at $3.58M in Q4 2025. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Atom Investors held 1,373 shares of Chemed worth $519K as of Q1 2026.
  • Atom Investors sold 7,000 Chemed shares in Q1 2026, an estimated $3M.
  • Chemed made up 0.04% of Atom Investors's portfolio in Q1 2026, its #474 holding.
  • Atom Investors first reported a position in Chemed in Q1 2021 and has held it in 6 quarters since.
  • Atom Investors's Chemed position peaked at $3.58M in Q4 2025.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.